Apontis Pharma AG (APPH.DE)

EUR 11.45

(2.69%)

Long Term Debt Summary of Apontis Pharma AG

  • Apontis Pharma AG's latest annual long term debt in 2023 was 6 Million EUR , down 0.0% from previous year.
  • Apontis Pharma AG's latest quarterly long term debt in 2024 Q2 was - EUR , down 0.0% from previous quarter.
  • Apontis Pharma AG reported annual long term debt of - EUR in 2022, down 0.0% from previous year.
  • Apontis Pharma AG reported annual long term debt of - EUR in 2021, down 0.0% from previous year.
  • Apontis Pharma AG reported quarterly long term debt of 6 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Apontis Pharma AG reported quarterly long term debt of 6 Million EUR for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Apontis Pharma AG (2023 - 2018)

Historical Annual Long Term Debt of Apontis Pharma AG (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 6 Million EUR 0.0%
2022 - EUR 0.0%
2021 - EUR 0.0%
2020 - EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%

Peer Long Term Debt Comparison of Apontis Pharma AG

Name Long Term Debt Long Term Debt Difference
MPH Health Care AG 8.33 Million EUR 28.0%
Dermapharm Holding SE 950.7 Million EUR 99.369%
Evotec SE 477.11 Million EUR 98.742%
MERCK Kommanditgesellschaft auf Aktien 8.84 Billion EUR 99.932%
PharmaSGP Holding SE 65.37 Million EUR 90.821%
SynBiotic SE 2.89 Million EUR -107.365%